AirAsia X Berhad (KLSE:AAX)
Malaysia · Delayed Price · Currency is MYR 1.500
-0.010 (-0.66%)
At close: Aug 7, 2025
Theseus Pharmaceuticals Balance Sheet
Financials in millions MYR. Fiscal year is January - December.
Millions MYR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2016 - 2020 |
Cash & Equivalents | 51.82 | 162.58 | 57.69 | 18.63 | 10.22 | 14.09 | Upgrade |
Short-Term Investments | 126.19 | 115.56 | 125.26 | 158.08 | 15.14 | 54.38 | Upgrade |
Cash & Short-Term Investments | 178.01 | 278.14 | 182.95 | 176.71 | 25.36 | 68.47 | Upgrade |
Cash Growth | 201.95% | 52.03% | 3.53% | 596.70% | -62.95% | -77.74% | Upgrade |
Accounts Receivable | 526.37 | 451.03 | 451.16 | 181.03 | 22.55 | 156.27 | Upgrade |
Other Receivables | 9.13 | 8.04 | 15.08 | 73.77 | 5.62 | 7.5 | Upgrade |
Receivables | 535.5 | 459.06 | 466.24 | 254.8 | 28.17 | 163.78 | Upgrade |
Inventory | 9.1 | 8.69 | 6.97 | 9.19 | - | - | Upgrade |
Prepaid Expenses | 42.21 | 45.92 | 46.92 | 46.81 | 17.51 | 27.97 | Upgrade |
Other Current Assets | 17.31 | - | - | 62.63 | 9.42 | 89.8 | Upgrade |
Total Current Assets | 782.12 | 791.81 | 703.08 | 550.15 | 80.46 | 350.02 | Upgrade |
Property, Plant & Equipment | 1,313 | 1,230 | 1,342 | 1,086 | 133.72 | - | Upgrade |
Long-Term Accounts Receivable | - | - | - | - | - | 23.43 | Upgrade |
Long-Term Deferred Tax Assets | 573.97 | 574.37 | 601.91 | 612.24 | - | - | Upgrade |
Long-Term Deferred Charges | - | - | - | - | - | 23.32 | Upgrade |
Other Long-Term Assets | 737.16 | 762.99 | 490.84 | 234.25 | 147.44 | 1,548 | Upgrade |
Total Assets | 3,406 | 3,359 | 3,138 | 2,483 | 361.62 | 1,944 | Upgrade |
Accounts Payable | 185.38 | 21.54 | 63.3 | 92.36 | 76.51 | 1,175 | Upgrade |
Accrued Expenses | 118.97 | 122.63 | 62.35 | 21.25 | - | 25,526 | Upgrade |
Current Portion of Long-Term Debt | - | - | - | - | - | 292.92 | Upgrade |
Current Portion of Leases | 205.28 | 191.25 | 152.39 | 57.03 | 0 | 6,474 | Upgrade |
Current Unearned Revenue | 345.53 | 543.75 | 612.3 | 391.37 | 572.5 | 506.95 | Upgrade |
Other Current Liabilities | 355.25 | 437.27 | 351.33 | 358.27 | 201.49 | 435.04 | Upgrade |
Total Current Liabilities | 1,210 | 1,316 | 1,242 | 920.29 | 850.5 | 34,409 | Upgrade |
Long-Term Leases | 1,285 | 1,223 | 1,360 | 1,005 | - | 0 | Upgrade |
Long-Term Unearned Revenue | 2.58 | 39.25 | 55.32 | 352.14 | - | 0.59 | Upgrade |
Other Long-Term Liabilities | 528.79 | 451.46 | 364.77 | 464.14 | 289.25 | 1,102 | Upgrade |
Total Liabilities | 3,027 | 3,030 | 3,021 | 2,742 | 1,140 | 35,512 | Upgrade |
Common Stock | 51.03 | 51.03 | 51.03 | 1.53 | 1.53 | 1,534 | Upgrade |
Retained Earnings | 328.06 | 277.85 | 70.73 | -260.78 | -779.86 | -35,102 | Upgrade |
Comprehensive Income & Other | 0.09 | -0.04 | -5.58 | 0.01 | 0.2 | 0.73 | Upgrade |
Shareholders' Equity | 379.18 | 328.85 | 116.18 | -259.23 | -778.14 | -33,567 | Upgrade |
Total Liabilities & Equity | 3,406 | 3,359 | 3,138 | 2,483 | 361.62 | 1,944 | Upgrade |
Total Debt | 1,490 | 1,414 | 1,512 | 1,062 | 0 | 6,767 | Upgrade |
Net Cash (Debt) | -1,312 | -1,136 | -1,329 | -885.77 | 25.36 | -6,698 | Upgrade |
Net Cash Per Share | -2.94 | -2.54 | -2.97 | -2.14 | 0.06 | -1.61 | Upgrade |
Filing Date Shares Outstanding | 447.07 | 447.07 | 447.07 | 414.81 | 414.82 | 414.81 | Upgrade |
Total Common Shares Outstanding | 447.07 | 447.07 | 447.07 | 414.81 | 414.82 | 414.81 | Upgrade |
Working Capital | -428.29 | -524.62 | -538.59 | -370.15 | -770.04 | -34,059 | Upgrade |
Book Value Per Share | 0.85 | 0.74 | 0.26 | -0.62 | -1.88 | -80.92 | Upgrade |
Tangible Book Value | 379.18 | 328.85 | 116.18 | -259.23 | -778.14 | -33,567 | Upgrade |
Tangible Book Value Per Share | 0.85 | 0.74 | 0.26 | -0.62 | -1.88 | -80.92 | Upgrade |
Machinery | - | 220.09 | 201.61 | 186.62 | - | 409.44 | Upgrade |
Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.